Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. Mähler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M, Zimmermann BF, Krannich A, Paul F, Boschmann M Am J Clin Nutr. 2015 Mar; 101(3):487-95. Epub 2015 Jan 14. PMID: 25733633. Abstract CommentRecommendBookmarkWatch